Coronavirus (COVID-19) Collection
Differential clinical characteristics and performance of home antigen tests between parents and children after household transmission of SARS-CoV-2 during the Omicron variant pandemic
The SARS-CoV-2 Omicron variant (B.1.1.529) BA.2 pandemic struck in 2022. Children seemed to have a lower rate of infection than adults at the beginning of the COVID-19 pandemic, but the clinical scenario changed, especially after the Omicron variant outbreak [1]. The transmission of SARS-CoV-2 may vary according to different viral variants, settings, and individuals, and understanding the transmission rate and factors associated with transmission may help further control COVID-19. To this end, the difference in clinical symptoms and overall household transmission rate between children and adults needs further investigation.Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022
From the end of 2020, multiple variants of concern have emerged during the COVID-19 pandemic. Most recently, the Omicron variant has become dominant worldwide over other strains, with the potential for the emergence of other new variants or subvariants in the future. The Omicron variants have demonstrated increasing transmissibility and therefore are more challenging to control (Kraemer et al., 2021; World Health Organization, 2022). In general, increased transmissibility for a variant indicates an increased transmission strength, a higher transmission speed, or both.Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China
COVID-19, a new contagious respiratory disease, occurred at the end of 2019, in Wuhan, China (Zu et al., 2020), and spread globally rapidly. Although various endeavors have been taken, the disease has not been well controlled except in a few countries. Up to now, COVID-19 has led to over millions of deaths, and become a pandemic and global public health crisis. The pathogen of COVID-19 was quickly confirmed to be SARS-CoV-2 (Schijns et al., 2020).The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19
SARS-CoV-2, the virus causing Coronavirus disease 2019 (COVID-19), has infected more than 92 million people and lead to the death of more than 1.9 million people worldwide since its outbreak in December 2019 (WHO, 2020). The disease has a wide range of presentations, from asymptomatic infection to fever, cough, shortness of breath and the loss of taste and smell. Symptoms normally appear 2–14 days following exposure to the virus and may develop into mild upper respiratory tract infections or progress to severe pneumonia, which can progress to acute respiratory distress, shock, multiorgan failure and death (Huang et al., 2020; Wang et al., 2020).Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions
The outbreak of novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-induced disease, COVID-19, spread rapidly from Wuhan, China, in December 2019. This led to China experiencing a major public health emergency with over 83,000 confirmed cases and 4634 deaths as of June 2020 (Rai et al., 2020). Although there are a few newly developed vaccines and treatments, it is conceivable that without some impact on transmission, the virus will continue to circulate, infect, and cause serious disease, in certain segments of the unvaccinated population.Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis
A combination of physical distancing measures, if implemented early, can be effective in containing COVID-19—tight border controls to limit importation of cases, encouraging physical distancing, moderately stringent measures such as working from home, and a full lockdown in the case of a probable uncontrolled outbreak.
